Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Cher

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Urology Practice|August 18, 2023
Editorial CommentaryBrian R Lane, Michael L Cher
Cancer Metastasis Reviews|October 29, 2002
Prostate cancer diagnosis, staging and survivalVivek Narain, Michael L Cher, David P Wood
American Journal of Cancer Research|October 22, 2011
Circulating tumor cells: finding the needle in the haystackXiaoning Zhe, Michael L Cher, R Daniel Bonfil
The Journal of Urology|April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. ReplyKevin B Ginsburg, Michael L Cher, , et al.
The Journal of Urology|July 28, 2020
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative ExperienceKevin B Ginsburg, Michael L Cher, James E Montie
European Urology Open Science|October 3, 2025
Tumor Rupture During Partial Nephrectomy: More Questions than AnswersBrian R Lane, Michael L Cher, Lauren E Lane
Cureus|June 29, 2026
Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance AthleteHunter Cohn, Ava Zamani, Michael Sessine, et al.
BMC Cancer|October 23, 2019
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth modelLouie Semaan, Navneet Mander, Michael L Cher, et al.
Cancer Treatment and Research|March 27, 2004
Matrix metalloproteinaes and bone metastasisR Daniel Bonfil, Pamela Osenkowski, Rafael Fridman, et al.
Cancer Journal (Sudbury, Mass.)|January 25, 2020
Pathologically Node-Positive Prostate Cancer: Casting for Cure When the Die Is Cast?Kevin B Ginsburg, Michael L Cher, Alexander Kutikov, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Urology Practice|August 18, 2023
Editorial CommentaryBrian R Lane, Michael L Cher
Cancer Metastasis Reviews|October 29, 2002
Prostate cancer diagnosis, staging and survivalVivek Narain, Michael L Cher, David P Wood
American Journal of Cancer Research|October 22, 2011
Circulating tumor cells: finding the needle in the haystackXiaoning Zhe, Michael L Cher, R Daniel Bonfil
The Journal of Urology|April 5, 2021
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. ReplyKevin B Ginsburg, Michael L Cher, , et al.
The Journal of Urology|July 28, 2020
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative ExperienceKevin B Ginsburg, Michael L Cher, James E Montie
European Urology Open Science|October 3, 2025
Tumor Rupture During Partial Nephrectomy: More Questions than AnswersBrian R Lane, Michael L Cher, Lauren E Lane
Cureus|June 29, 2026
Reduction in Wearable-Derived Maximal Oxygen Consumption (VO₂max) During Tamsulosin Use in an Endurance AthleteHunter Cohn, Ava Zamani, Michael Sessine, et al.
BMC Cancer|October 23, 2019
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth modelLouie Semaan, Navneet Mander, Michael L Cher, et al.
Cancer Treatment and Research|March 27, 2004
Matrix metalloproteinaes and bone metastasisR Daniel Bonfil, Pamela Osenkowski, Rafael Fridman, et al.
Cancer Journal (Sudbury, Mass.)|January 25, 2020
Pathologically Node-Positive Prostate Cancer: Casting for Cure When the Die Is Cast?Kevin B Ginsburg, Michael L Cher, Alexander Kutikov, et al.
Pageof 12